Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
35.6 HKD | -1.66% | +10.22% | -27.49% |
Apr. 30 | Keymed Biosciences' Allergy Treatment NDA Accepted by NMPA | MT |
Apr. 29 | Keymed Biosciences Allergy Drug Achieves Phase III Clinical Trial End Points | MT |
- Stock Market
- Equities
- 2162 Stock
- News Keymed Biosciences Inc.
- MarketScreener Strategies